Diabetes and Partnership: Evaluation of a Diabetes Education Module
NCT ID: NCT02076568
Last Updated: 2019-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
201 participants
INTERVENTIONAL
2014-02-28
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes and Sports: Evaluation of a Diabetes Education Module
NCT02076542
Diabetes and Social Issues: Evaluation of a Diabetes Education Module
NCT02076555
Diabetes and Travel: Evaluation of a Diabetes Education Module - a Randomized Controlled Trial (PRIMO_Travel)
NCT02077686
Empowerment Training on Type 2 Diabetes Patients on Empowerment Levels and Clinical Findings
NCT05680207
Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care
NCT00715585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Education - Diabetes and Partnership
Patients randomized to this arm, will participate immediately in the education module "Diabetes and Partnership"
Education - Diabetes and Partnership
Based on the treatment and education programme PRIMAS a problem-specific education module regarding "Diabetes and Partnership" was created. The module covers specific and detailed aspects of the topic "partnership" such as dealing with hypoglycemia, late complications, and talking about diabetes in a relationship. With this module, a more comprehensive education of patients with specific interest in these topics is possible.
Waiting-list control group
Patients in the control group will get the education with the education module after completion of the 6-month follow-up
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education - Diabetes and Partnership
Based on the treatment and education programme PRIMAS a problem-specific education module regarding "Diabetes and Partnership" was created. The module covers specific and detailed aspects of the topic "partnership" such as dealing with hypoglycemia, late complications, and talking about diabetes in a relationship. With this module, a more comprehensive education of patients with specific interest in these topics is possible.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* specific interest in "Diabetes and Partnership"
* wish to participate in group education
* informed consent
* fluent in reading and speaking German language
Exclusion Criteria
* severe organic disease (e.g. terminal renal disease, cancer with poor prognosis)
* current treatment of a mental disease
* cognitive impairment
* dementia
* pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Forschungsinstitut der Diabetes Akademie Mergentheim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Norbert Hermanns
Head of the Research Institut Diabetes Academy Mergentheim
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Norbert Hermanns, PhD
Role: PRINCIPAL_INVESTIGATOR
Forschungsinstitut der Diabetes Akademie Mergentheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Institute of the Diabetes Academy Mergentheim (FIDAM)
Bad Mergentheim, , Germany
Zentrum für Diabetologie Bergedorf
Hamburg, , Germany
Diabeteszentrum Ludwigsburg
Ludwigsburg, , Germany
Diabetologische Schwerpunktpraxis Neuss
Neuss, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NH022014_4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.